| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1993 Oxford University Press
other |
What Does the Odds Ratio Estimate in a Case-Control Study?
* Department of Medicine, Wellington School of Medicine PO Box 7343, Wellington, New Zealand
Formerly at IARC 150 cours Albert-Thomas, 69372 Lyon, France
The use of the term ‘odds ratio’ in reporting the findings of case-control studies is technically correct, but is often misleading. The meaning of the odds ratio estimates obtained in a case-control study differs according to whether controls are selected from person-time at risk (the study base), persons at risk (the base-population at risk at the beginning of follow-up), or survivors (the population at risk at the end of follow-up). These three methods of control selection correspond to estimating the rate ratio, risk ratio, or the odds ratio respectively, by means of calculating the odds ratio in the subjects actually studied. None of these estimation procedures depends on any rare disease assumption. Where the rare disease assumption is relevant is whether the effect which is estimated (e.g. the odds ratio) is approximately equal to some other effect measure of interest (e.g. the risk ratio or rate ratio) in the underlying study base. To avoid confusion on this issue, authors should be encouraged to not only specify the manner in which controls have been selected (e.g. by density sampling) but also the corresponding effect measure which is being estimated (e.g. the rate ratio) by the ‘odds ratio’ which is obtained in a case-control analysis.
Received 1 June 1993
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Parish, R. Peto, A. Palmer, R. Clarke, S. Lewington, A. Offer, G. Whitlock, S. Clark, L. Youngman, P. Sleight, et al. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls Eur. Heart J., September 1, 2009; 30(17): 2137 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Knol, J. P. Vandenbroucke, P. Scott, and M. Egger What Do Case-Control Studies Estimate? Survey of Methods and Assumptions in Published Case-Control Research Am. J. Epidemiol., November 1, 2008; 168(9): 1073 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kudoh, H. Kato, Y. Nishiwaki, M. Fukuoka, K. Nakata, Y. Ichinose, M. Tsuboi, S. Yokota, K. Nakagawa, M. Suga, et al. Interstitial Lung Disease in Japanese Patients with Lung Cancer: A Cohort and Nested Case-Control Study Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1348 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Brunelli, J. D. Lewis, M. Gupta, S. M. Latif, M. G. Weiner, and H. I. Feldman Risk of Kidney Injury Following Oral Phosphosoda Bowel Preparations J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3199 - 3205. [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Vandenbroucke, E. v. Elm, D. G. Altman, P. C. Gotzsche, C. D. Mulrow, S. J. Pocock, C. Poole, J. J. Schlesselman, M. Egger, and for the STROBE initiative Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration Ann Intern Med, October 16, 2007; 147(8): W-163 - W-194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Marciante, J. C. Bis, M. J. Rieder, A. P. Reiner, T. Lumley, S. A. Monks, C. Kooperberg, C. Carlson, S. R. Heckbert, and B. M. Psaty Renin-Angiotensin System Haplotypes and the Risk of Myocardial Infarction and Stroke in Pharmacologically Treated Hypertensive Patients Am. J. Epidemiol., July 1, 2007; 166(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Psaty, N. L. Smith, S. R. Heckbert, H. L. Vos, R. N. Lemaitre, A. P. Reiner, D. S. Siscovick, J. Bis, T. Lumley, W. T. Longstreth Jr, et al. Diuretic Therapy, the {alpha}-Adducin Gene Variant, and the Risk of Myocardial Infarction or Stroke in Persons With Treated Hypertension JAMA, April 3, 2002; 287(13): 1680 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L J Walsh, C A Wong, J Oborne, S Cooper, S A Lewis, M Pringle, R Hubbard, and A E Tattersfield Adverse effects of oral corticosteroids in relation to dose in patients with lung disease Thorax, April 1, 2001; 56(4): 279 - 284. [Abstract] [Full Text]
|
|
|
|
|
|
B. M. Psaty, N. L. Smith, R. N. Lemaitre, H. L. Vos, S. R. Heckbert, A. Z. LaCroix, and F. R. Rosendaal Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Myocardial Infarction in Postmenopausal Women JAMA, February 21, 2001; 285(7): 906 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Poikolainen, R. Kanerva, and J. Lonnqvist Fear of nuclear war -- A risk factor for mental disorder among adolescent girls? Young, December 1, 2000; 8(3): 37 - 46. [PDF]
|
|